Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression

Archive ouverte

Goossens, Pieter | Rodriguez-Vita, Juan | Etzerodt, Anders | Massé, Marion | Rastoin, Olivia | Gouirand, Victoire | Ulas, Thomas | Papantonopoulou, Olympia | van Eck, Miranda | Auphan-Anezin, Nathalie | Bebien, Magali | Verthuy, Christophe | Manh, Thien Phong Vu | Turner, Martin | Dalod, Marc | Schultze, Joachim L. | Lawrence, Toby

Edité par CCSD ; Elsevier -

International audience. Macrophages possess intrinsic tumoricidal activity, yet tumor-associated macrophages (TAMs) rapidly adopt an alternative phenotype within the tumor microenvironment that is marked by tumor-promoting immunosuppressive and trophic functions. The mechanisms that promote such TAM polarization remain poorly understood, but once identified, they may represent important therapeutic targets to block the tumor-promoting functions of TAMs and restore their anti-tumor potential. Here, we have characterized TAMs in a mouse model of metastatic ovarian cancer. We show that ovarian cancer cells promote membrane cholesterol efflux and depletion of lipid rafts from macrophages. Increased cholesterol efflux promoted IL-4-mediated reprogramming, including inhibition of IFN gamma-induced gene expression. Genetic deletion of ABC transporters, which mediate cholesterol efflux, reverts the tumor-promoting functions of TAMs and reduces tumor progression. These studies reveal an unexpected role for membrane-cholesterol efflux in driving TAM-mediated tumor progression while pointing to a potentially novel anti-tumor therapeutic strategy.

Suggestions

Du même auteur

Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone

Archive ouverte | Habbeddine, Mohamed | CCSD

International audience. Graphical Abstract Highlights d RANK deletion does not affect DC survival or T cell priming in the context of infection d RANK is required for memory CD8 T cell activation in response to vira...

NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity

Archive ouverte | Ghislat, Ghita | CCSD

International audience. Conventional type 1 dendritic cells (cDC1s) are critical for antitumor immunity. They acquire antigens from dying tumor cells and cross-present them to CD8 + T cells, promoting the expansion ...

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of `soluble CD163' in plasma

Archive ouverte | Etzerodt, Anders | CCSD

International audience. CD163 is the macrophage receptor for uptake of hemoglobin-haptoglobin complexes. The human receptor can be shed from the macrophage surface owing to a cleavage site for the inflammationinduci...

Chargement des enrichissements...